Look for:

Products

BRISTOL-MYERS SQUIBB CO.


ISIN:
US1101221083
WKN:
110122108

2022/11/25 19:00:01
Price
79.24 USD
Difference 0.13% (0.10)

General attributes

ISINUS1101221083
SymbolBMY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)162,525 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)74.50 USD (100)
Ask (Ask size)79.24 USD (500)
Open79.31 USD
High79.78 USD
Low79.14 USD
Close (prev. day)79.14 USD
VWAP79.370495 USD
Volume (pcs)4,734,955
Trading volume375,840,606.81
Number of trades36,139
Last size352,630

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: BRISTOL-MYERS SQUIBB CO.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/11/25 19:00:01
Price
79.24 USD
Difference 0.13% (0.10)

General attributes

ISINUS1101221083
SymbolBMY
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)162,525 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)74.50 USD (100)
Ask (Ask size)79.24 USD (500)
Open79.31 USD
High79.78 USD
Low79.14 USD
Close (prev. day)79.14 USD
VWAP79.370495 USD
Volume (pcs)4,734,955
Trading volume375,840,606.81
Number of trades36,139
Last size352,630

Performance and Risk

6m1Y3Y
Perf (%)+5.25%+49.63%+49.33%
Perf (abs.)+3.80+25.26+25.16
Beta0.260.250.49
Volatility23.6522.3424.26
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)78.73 USD (7,142,500)
Ø price 30 days | Ø volume 30 days (pcs.)76.10 USD (9,115,493)
Ø price 100 days | Ø volume 100 days (pcs.)73.28 USD (9,411,607)
Ø price 250 days | Ø volume 250 days (pcs.)71.24 USD (12,544,100)
YTD High | date81.17 USD (2022/11/09)
YTD Low | date60.86 USD (2022/01/06)
52 Weeks High | date81.17 USD (2022/11/09)
52 Weeks Low | date53.22 USD (2021/11/30)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/11/2517:3576.57 EUR0.025
Vienna Stock Exchange2022/11/2517:3276.57 EUR0.002
Tradegate2022/11/2522:2676.16 EUR0.1124
Stuttgart2022/11/2516:5376.41 EUR0.0110
SIX Swiss Exchange2019/07/0305:5545.30 USD0.001
SIX Swiss Exchange2019/06/2817:3544.39 CHF0.001
NYSE2022/11/2519:0079.24 USD375.8436,139
Munich2022/11/2508:0076.06 EUR0.001
London Stock Exchange European Trade Reporting2022/11/2517:3079.355 USD0.004
Hanover2022/11/2508:0475.68 EUR0.001
Hamburg2022/11/2508:0475.68 EUR0.001
Frankfurt2022/11/2516:0176.44 EUR0.002
Duesseldorf2022/11/2521:0076.05 EUR0.0012
Berlin2022/11/2508:0075.64 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=716&ID_TYPE_IMAGE_LOGO=2

Contact Details

BRISTOL MYERS SQUIBB CO.
- -
430 East 29th Street - 10016 New York
Telefon: 1-212-546-4000
Fax: -
E-mail: -

PDF Downloads

Company report: BRISTOL-MYERS SQUIBB CO.PDF Download

Company Profile

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Members of Management Board

Deepak BhattMember of Board of Directors
Julia HallerMember of Board of Directors
Karen VousdenMember of Board of Directors
Manuel Hidalgo MedinaMember of Board of Directors
Derica RiceMember of Board of Directors
Gerald StorchMember of Board of Directors
Paula PriceMember of Board of Directors
Peter ArduiniMember of Board of Directors
Phyllis YaleMember of Board of Directors
Theodore SamuelsMember of Board of Directors
Giovanni CaforioChairman of Managing Board
Christopher BoernerMember of Executive Committee
Adam DubowMember of Executive Committee
Ann M. PowellMember of Executive Committee
Catalina VargasMember of Executive Committee
David ElkinsMember of Executive Committee
Elizabeth A. MilyMember of Executive Committee
Lou SchmuklerMember of Executive Committee
Michelle WeeseMember of Executive Committee
Paul von AutenriedMember of Executive Committee
Rupert VesseyMember of Executive Committee
Samit HirawatMember of Executive Committee
Sandra LeungMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.